It has previously been suggested that the mechanism of BCG therapeutic effects on BC is related to its ability to reduce telomerase (TERT) activity [30] — we may speculate that c.1-146G>A mutated tumors might be more susceptible to the reduction of telomerase activity by BCG. Here, TERT is linked to breast cancer.